"Across our three hospitals and eight satellite sites, Scarborough Health Network (SHN) is shaping the future of care. Our many programs and services are designed around the needs of one of Canada’s most vibrant and diverse communities. We are home to North America’s largest nephrology program, as well as the designated cardiac care and spine centre for Scarborough and surrounding communities to the east. We are proud to be a community-affiliated teaching site for the University of Toronto and partner with a number of other universities and colleges, helping to train the next generation of health care professionals."

During the past decade, The Scarborough Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Scarborough Hospital" #1 sponsor was "NCIC Clinical Trials Group" with 5 trials, followed by "Ontario Clinical Oncology Group (OCOG)" with 4 trials sponsored, "The Hospital for Sick Children" with 3 trials sponsored, "Sunnybrook Health Sciences Centre" with 2 trials sponsored and "University Health Network, Toronto" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Scarborough Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Ontario Ministry of Health and Long Term Care" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "The Scarborough Hospital" are "Breast Cancer" (3 trials), "COVID-19" (3 trials), "Bladder Cancer" (2 trials), "Ovarian Cancer" (2 trials) and "Arteriovenous Fistula" (1 trials). Many other conditions were trialed in "The Scarborough Hospital" in a lesser frequency.

Most popular intervention types in "The Scarborough Hospital" are "Drug" (13 trials), "Device" (6 trials), "Behavioral" (4 trials), "Biological" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "alvocidib" (2 trials), "gemcitabine hydrochloride" (2 trials), "paclitaxel" (2 trials), "ACHRU-Community Partnership Program (CPP)" (1 trials) and "Anti-Arrhythmic Drug Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Scarborough Hospital" are 26 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "The Scarborough Hospital". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in The Scarborough Hospital, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Scarborough Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".